top of page
News
Feb 11, 2025
CTO of La Jolla Labs, Jeff Milton, Interviewed by Technology Networks for new Article: Tackling Rare Diseases With RNA Therapeutics
Feb 5, 2025
La Jolla Labs, Inc. Announces Leadership Transition as Company Evolves from Technology to Therapeutics
Oct 29, 2024
CEO of La Jolla Labs, Jeff Milton, presents at the Inaugural RNA and AI Symposium
Jul 10, 2023
La Jolla Labs Partners with Pitt Hopkins Research Foundation: Investigating the Feasibility of ASO Therapy in Pitt Hopkins Syndrome
Jun 1, 2023
ONCE UPON A GENE - EPISODE 189 - Developing Personalized Therapeutics for Ultra Rare Patients with La Jolla Labs CEO Jeff Milton
Feb 28, 2023
How Artificial Intelligence Will Drive Rare Disease Therapeutics Jeff Milton CEO - La Jolla Labs
Jan 30, 2023
Jeff Milton, CEO at La Jolla Labs Inc., presented at the N=1 Collaborative Seminar Series: “A Model for Sustainable Discovery in Rare Disease”
Contact Us
bottom of page